IFA Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
IFA Talk Podcast – listen to the latest episode
Trending Articles
-
The Exeter announces agreement with iGPR to streamline requests for medical information
UK health and life insurer, The Exeter, has announced a new agreement with iGPR, the market-leading provider of redactio…
-
Podcast #136: Succession planning for business owners under the new IHT rules, with Bishop Fleming’s Peter Ball
In this week’s episode of IFA Talk, we dive into the world of taxes, following changes to IHT rules. Recent changes and…
-
Freedom Health Insurance launches Freedom 360: a powerful new health and wellbeing toolkit tailored for group clients
Launching on 1st October 2025, Freedom Health Insurance is proud to announce Freedom 360, a comprehensive health and wel…
-
UK state pension age review launched amid rising demographic pressures
Dr Suzy Morrissey today announced she has been appointed by the Department for Work and Pensions (DWP) Secretary of Stat…
-
AI for pensions: transformative potential, responsible use
The pensions industry is entering a new era driven by the transformative potential of AI. From enhancing operational eff…
-
Spectre of inheritance tax sees grandparents’ wills changed after death to skip a generation
As the government seeks to balance the books, even the modestly well-off fear hefty inheritance tax bills. This is drivi…
-
Insurers warned: misconceptions around skin cancer could cost lives
Recent consumer research from Vitality has revealed worrying attitudes of men in the UK to skin cancer and sun protectio…
-
UK CPI preview: inflation, rate cuts, and the pound’s path forward
Written by Daniela Sabin Hathorn, senior market analyst at Capital.com The UK Consumer Price Index (CPI) will be release…
-
Inflation hits 3.8%: industry experts share their insights
The latest inflation data shows the Consumer Prices Index (CPI) has risen to 3.8% in July, up from 3.6% in June, marking…
-
Bank of England faces policy pivot
Written by Mark Michaelides, chief commercial officer of lender Molo While the Bank of England’s Monetary Policy Commit…
Exclusives
Latest Publications
Explore our latest reports, magazines and special supplements
More Latest News
-
London pre-open: Stocks seen up on positive Asian cues
(Sharecast News) – London stocks were set to edge up at the open on Monday following a positive Asian session, as investors…
-
SThree to resume dividend payments
(Sharecast News) – Despite seeing both revenues and pre-tax profits take a big hit in 2020, recruitment firm SThree will resume dividend…
-
This is why day trading is impossible
@peter_IFAMAG reads Twitter so you don’t have to. Bloomberg reports nearly all of the gains made in the S&P 500 came overnight…
-
Shell buys EV charging network operator ubitricity
(Sharecast News) – Royal Dutch Shell is buying European electric vehicle (EV) charging network operator ubitricity for an undisclosed sum, the two…
-
Barings: The Best Way to Get a Car Out of a Ditch
This week’s Leading Thoughts from Barings is by Christopher Smart, Chief Global Strategist & Head of the Barings Investment Institute, outlining the…
-
Asos in exclusive talks to buy Topshop out of administration
(Sharecast News) – Asos is in exclusive talks to acquire Topshop and a number of other Arcadia-owned brands out of administration, it…
-
Covid-19 delays TP Icap’s post-Brexit EU operation
(Sharecast News) – TP Icap said Covid-19 prevented the company from staffing European offices to comply with post-Brexit rules and that its…
-
JTC full-year results seen in line with guidance, consensus
(Sharecast News) – JTC said on Monday that full-year results are set to be in line with management guidance and consensus expectations…
-
TI Fluid systems to pay interim dividend; Guides for better EBIT margin
(Sharecast News) – TI Fluid Systems said it was paying a first quarter interim dividend of 6.74 euro cents a share, but…
-
AstraZeneca reports positive test results, new approval for ‘Calquence’
(Sharecast News) – AstraZeneca said on Monday that positive high-level results from the ‘ELEVATE-RR’ phase 3 trial showed ‘Calquence’, or acalabrutinib, met…